$LMFA
LM FUNDING AMERICA, INC. Stock $lmfa

$lmfa Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000156459021044649 Filed on August 16, 2021

Income Statement

Concept	2021 Q2	2020 Q4	2020 Q2
Revenue	$328.4K	$330.0K	$342.5K
YoY Change	-4.13%	-35.29%	-59.22%
Cost Of Revenue	$843.0K	$430.0K	$480.0K
YoY Change	75.62%	30.3%	-7.69%
Gross Profit	$13.63M	-$100.0K	-$140.0K
YoY Change	-9832.76%	-155.56%	-207.69%
Gross Profit Margin	4149.36%	-30.3%	-40.87%
Selling, General & Admin	$96.02K	$380.0K	$74.73K
YoY Change	28.49%	-28.3%	-40.86%
% of Gross Profit	0.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.990K	$0.00	$4.110K
YoY Change	21.41%	-100.0%	-25.62%
% of Gross Profit	0.04%
Operating Expenses	$641.6K	$200.0K	$774.8K
YoY Change	-17.19%	-41.18%	-36.9%
Operating Profit	-$313.2K	-$300.0K	-$432.2K
YoY Change	-27.53%	87.5%	11.45%
Interest Expense	$189.00	$0.00	$5.732K
YoY Change	-96.7%	-100.0%	-89.13%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	$11.27M	-$300.0K	-$438.0K
YoY Change	-2672.82%	-83.78%	-16.01%
Income Tax	$13.78K
% Of Pretax Income	0.12%
Net Earnings	$11.11M	-$300.0K	-$438.0K
YoY Change	-2636.14%	-83.52%	-2.78%
Net Earnings / Revenue	3382.46%	-90.91%	-127.86%
Basic Earnings Per Share	$2.05		-$0.56
Diluted Earnings Per Share	$2.05	-$97.09K	-$0.56
COMMON SHARES
Basic Shares Outstanding	5.414M		783.4K
Diluted Shares Outstanding	5.423M		783.4K

Balance Sheet

Concept	2021 Q2	2020 Q4	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$30.01M	$11.55M	$6.240M
YoY Change	380.93%	979.44%	101.94%
Cash & Equivalents	$22.17M	$11.55M	$6.289M
Short-Term Investments	$7.837M
Other Short-Term Assets	$157.2K	$400.0K	$100.0K
YoY Change	57.2%	166.67%	-9.09%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$30.31M	$12.12M	$6.650M
YoY Change	355.73%	583.57%	107.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.929K	$6.171K	$220.0K
YoY Change	-96.4%	-25.54%	625.4%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$2.295M	$20.00K	$10.00K
YoY Change	22852.0%	-98.68%	-80.0%
Other Assets	$10.98K	$10.98K	$10.00K
YoY Change	9.84%	-0.34%	-75.0%
Total Long-Term Assets	$7.121M	$196.6K	$230.0K
YoY Change	2995.92%	-96.65%	-96.36%
TOTAL ASSETS
Total Short-Term Assets	$30.31M	$12.12M	$6.650M
Total Long-Term Assets	$7.121M	$196.6K	$230.0K
Total Assets	$37.43M	$12.32M	$6.880M
YoY Change	443.99%	61.21%	-27.76%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$174.2K	$160.0K	$170.0K
YoY Change	2.46%	-54.29%	1600.0%
Accrued Expenses	$108.6K		$100.0K
YoY Change	8.61%		400.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$96.26K	$0.00
YoY Change		38.42%
Long-Term Debt Due			$0.00
YoY Change
Total Short-Term Liabilities	$581.0K	$491.7K	$400.0K
YoY Change	45.26%	-88.06%	2.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$190.0K	$190.0K
YoY Change	-100.0%	-63.46%	-95.39%
Other Long-Term Liabilities	$12.68K	$170.0K	$120.0K
YoY Change	-89.43%	-37.04%	71.43%
Total Long-Term Liabilities	$29.95K	$253.8K	$310.0K
YoY Change	-90.34%	-63.18%	-92.6%
TOTAL LIABILITIES
Total Short-Term Liabilities	$581.0K	$491.7K	$400.0K
Total Long-Term Liabilities	$29.95K	$253.8K	$310.0K
Total Liabilities	$611.0K	$849.1K	$710.0K
YoY Change	-13.95%	-82.33%	-84.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.052M	-$18.54M
YoY Change		27.88%
Common Stock	$39.54M	$30.00M
YoY Change		73.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$36.49M	$11.46M	$6.175M
YoY Change
Total Liabilities & Shareholders Equity	$37.43M	$12.32M	$6.880M
YoY Change	443.99%	61.21%	-27.76%

Cashflow Statement

Concept	2021 Q2	2020 Q4	2020 Q2
OPERATING ACTIVITIES
Net Income	$11.11M	-$300.0K	-$438.0K
YoY Change	-2636.14%	-83.52%	-2.78%
Depreciation, Depletion And Amortization	$4.990K	$0.00	$4.110K
YoY Change	21.41%	-100.0%	-25.62%
Cash From Operating Activities	$7.677M	-$720.0K	-$170.0K
YoY Change	-4615.64%	188.0%	-56.41%
INVESTING ACTIVITIES
Capital Expenditures	-$3.190K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$3.992M	$90.00K	$1.530M
YoY Change	-360.95%	-106.25%	992.86%
Cash From Investing Activities	-$3.996M	$90.00K	$1.530M
YoY Change	-361.15%	-106.21%	992.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	689.8K	-50.00K	4.090M
YoY Change	-83.13%	-16.67%	-10325.0%
NET CHANGE
Cash From Operating Activities	7.677M	-720.0K	-170.0K
Cash From Investing Activities	-3.996M	90.00K	1.530M
Cash From Financing Activities	689.8K	-50.00K	4.090M
Net Change In Cash	4.371M	-680.0K	5.450M
YoY Change	-19.8%	-61.36%	-1979.31%
FREE CASH FLOW
Cash From Operating Activities	$7.677M	-$720.0K	-$170.0K
Capital Expenditures	-$3.190K	$0.00
Free Cash Flow	$7.680M	-$720.0K
YoY Change		188.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2021Q2	lmfa	Reverse Stock Split Percentage Of Common Stock ReverseStockSplitPercentageOfCommonStock	0.2
CY2020Q2	lmfa	Reverse Stock Split Percentage Of Issued Common Stock ReverseStockSplitPercentageOfIssuedCommonStock	0.1
CY2020Q2	lmfa	Reverse Stock Split Percentage Of Outstanding Common Stock ReverseStockSplitPercentageOfOutstandingCommonStock	0.5
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	11268119
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-437968
CY2021Q2	lmfa	Rental Revenue RentalRevenue	34588
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	11920
CY2020Q4	us-gaap	Assets Current AssetsCurrent	12120841
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	158399
CY2021Q2	us-gaap	Debt Securities Current DebtSecuritiesCurrent	7588538
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	399124
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6171
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	237033
CY2021Q2	lmfa	Real Estate Management And Disposal RealEstateManagementAndDisposal	29478
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	200000
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	5414
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	39538550
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2021Q2	lmfa	Reverse Stock Split Percentage Of Issued Common Stock ReverseStockSplitPercentageOfIssuedCommonStock	1
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0
CY2021Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Options Adjustments In Period Adjustment ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentsInPeriodAdjustment
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	lmfa	Share Based Compensation Arrangements By Share Based Payment Award Options Adjustments In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Options Adjustments In Period Adjustment ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdjustmentsInPeriodAdjustment
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	lmfa	Share Based Compensation Arrangements By Share Based Payment Award Options Adjustments In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsAdjustmentsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021Q2	us-gaap	Assets Current AssetsCurrent	30305920
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7929
CY2021Q2	us-gaap	Real Estate Investments Other RealEstateInvestmentsOther	80057
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	110870
CY2021Q2	us-gaap	Equity Method Investments EquityMethodInvestments	2295200
CY2021Q2	us-gaap	Investments In And Advances To Affiliates Balance Principal Amount InvestmentsInAndAdvancesToAffiliatesBalancePrincipalAmount	4615583
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	196589
CY2020Q4	us-gaap	Assets Assets	12317430
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	29948
CY2021Q2	us-gaap	Liabilities Liabilities	610974
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3052309
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	36491655
CY2021Q2	us-gaap	Minority Interest MinorityInterest	323914
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36815569
	lmfa	Administrative And Late Fees AdministrativeAndLateFees	58468
CY2021Q2	lmfa	Recoveries On Collection Of Assessments In Excess Of Cost RecoveriesOnCollectionOfAssessmentsInExcessOfCost	178769
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	96015
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	100000
CY2020Q2	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	100000
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3298
CY2021Q2	lmfa	Collection Cost CollectionCost	2701
CY2021Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	4069
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	641625
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-313240
CY2021Q2	lmfa	Realized Gain On Securities RealizedGainOnSecurities	8453570
	lmfa	Realized Gain On Securities RealizedGainOnSecurities	14125034
CY2021Q2	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	2501600
	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	2501600
CY2021Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	552494
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	1147886
CY2021Q2	lmfa	Interest Income InterestIncome	73884
	lmfa	Interest Income InterestIncome	86939
CY2021Q2	us-gaap	Interest Expense InterestExpense	189
CY2020Q2	us-gaap	Interest Expense InterestExpense	5732
	us-gaap	Interest Expense InterestExpense	653
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	157195
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	160667
CY2020Q4	us-gaap	Real Estate Investments Other RealEstateInvestmentsOther	18767
CY2020Q2	lmfa	Recoveries On Collection Of Assessments In Excess Of Cost RecoveriesOnCollectionOfAssessmentsInExcessOfCost	62362
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3083760
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10984
CY2021Q2	lmfa	Interest On Delinquent Association Fees InterestOnDelinquentAssociationFees	62673
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5414296
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3083760
CY2020Q2	lmfa	Interest On Delinquent Association Fees InterestOnDelinquentAssociationFees	170174
	lmfa	Recoveries On Collection Of Assessments In Excess Of Cost RecoveriesOnCollectionOfAssessmentsInExcessOfCost	208242
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5414296
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	30000000
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	37426543
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12317430
	lmfa	Administrative And Late Fees AdministrativeAndLateFees	31932
CY2020Q2	us-gaap	Revenues Revenues	342538
CY2020Q2	lmfa	Underwriting Fees And Other Revenues UnderwritingFeesAndOtherRevenues	41235
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	100000
CY2020Q2	us-gaap	Professional Fees ProfessionalFees	479581
	lmfa	Underwriting Fees And Other Revenues UnderwritingFeesAndOtherRevenues	69164
	lmfa	Rental Revenue RentalRevenue	66505
	lmfa	Rental Revenue RentalRevenue	81424
CY2021Q2	lmfa	Underwriting Fees And Other Revenues UnderwritingFeesAndOtherRevenues	35494
	lmfa	Underwriting Fees And Other Revenues UnderwritingFeesAndOtherRevenues	58197
	us-gaap	Revenues Revenues	504993
CY2020Q2	lmfa	Rental Revenue RentalRevenue	33344
CY2021Q2	us-gaap	Revenues Revenues	328385
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	154951
CY2021Q2	us-gaap	Professional Fees ProfessionalFees	360024
	us-gaap	Professional Fees ProfessionalFees	986576
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	195784
	us-gaap	Revenues Revenues	683734
	us-gaap	Professional Fees ProfessionalFees	842967
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-10000
CY2020Q2	lmfa	Real Estate Management And Disposal RealEstateManagementAndDisposal	14108
	lmfa	Real Estate Management And Disposal RealEstateManagementAndDisposal	47768
	lmfa	Real Estate Management And Disposal RealEstateManagementAndDisposal	99450
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7954
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4994
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13766
CY2020Q2	lmfa	Collection Cost CollectionCost	-20934
	lmfa	Collection Cost CollectionCost	4749
	lmfa	Collection Cost CollectionCost	-29255
CY2020Q2	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6844
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	11614
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	10638
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	774774
	us-gaap	Operating Expenses OperatingExpenses	2545897
	us-gaap	Operating Expenses OperatingExpenses	1676598
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-432236
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2040904
	us-gaap	Operating Income Loss OperatingIncomeLoss	-992864
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10984
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	7120623
CY2021Q2	us-gaap	Assets Assets	37426543
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	96257
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	298239
CY2021Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	174176
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	108611
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	581026
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	491689
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	12684
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	171648
CY2021Q2	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	17264
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	3084
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	185785
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	357433
CY2020Q4	us-gaap	Liabilities Liabilities	849122
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	29996257
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-18536224
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11463117
CY2020Q4	us-gaap	Minority Interest MinorityInterest	5191
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11468308
	lmfa	Recoveries On Collection Of Assessments In Excess Of Cost RecoveriesOnCollectionOfAssessmentsInExcessOfCost	84990
CY2020Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	74728
CY2021Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-146857
	us-gaap	Interest Expense InterestExpense	12626
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11727
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	16428
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.05
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	783433
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5423162
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	783433
	us-gaap	Share Based Compensation ShareBasedCompensation	132244
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11552943
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15819902
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1005490
CY2021Q2	lmfa	Income Tax Expense IncomeTaxExpense	13780
	lmfa	Income Tax Expense IncomeTaxExpense	17264
CY2021Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	11254339
CY2020Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-437968
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	15802638
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1005490
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	16428
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	11254339
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-437968
	us-gaap	Net Income Loss NetIncomeLoss	15802638
	us-gaap	Net Income Loss NetIncomeLoss	-989062
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-49059
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	184239
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	21858
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	142191
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	496546
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-11105
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-318723
CY2021Q2	us-gaap	Profit Loss ProfitLoss	11107482
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-437968
	us-gaap	Profit Loss ProfitLoss	15483915
	us-gaap	Profit Loss ProfitLoss	-989062
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.05
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.56
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.96
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-1.41
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare	0.02
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.05
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.96
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.38
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.05
CY2020Q2	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.56
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.95
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-1.41
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare	0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.95
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.38
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5414296
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5231909
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	715020
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5245656
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	715020
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4994
	lmfa	Right To Use Asset Depreciation RightToUseAssetDepreciation	49797
	lmfa	Right To Use Asset Depreciation RightToUseAssetDepreciation	51229
	lmfa	Debt Forgiveness DebtForgiveness	157251
	us-gaap	Allowance For Doubtful Accounts Receivable Recoveries AllowanceForDoubtfulAccountsReceivableRecoveries	200000
	us-gaap	Increase Decrease In Accrued Investment Income Receivable IncreaseDecreaseInAccruedInvestmentIncomeReceivable	86938
	lmfa	Gain Loss From Operations Of Discontinued Operations GainLossFromOperationsOfDiscontinuedOperations	16426
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	43623
	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	1147886
	lmfa	Unrealized Gain Loss On Convertible Debt Securities UnrealizedGainLossOnConvertibleDebtSecurities	2501600
	lmfa	Investment In Convertible Note Receivable InvestmentInConvertibleNoteReceivable	5000000
	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	14125034
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	15547454
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	29672488
	us-gaap	Proceeds From Sale Of Available For Sale Securities ProceedsFromSaleOfAvailableForSaleSecurities	49828
	lmfa	Investment In Marketable Securities InvestmentInMarketableSecurities	247997
	us-gaap	Operating Lease Payments OperatingLeasePayments	50353
	us-gaap	Operating Lease Payments OperatingLeasePayments	45742
	lmfa	Increase Decrease In Deferred Taxes IncreaseDecreaseInDeferredTaxes	17264
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6976580
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-438739
	lmfa	Proceeds From Underwriting And Origination Fees ProceedsFromUnderwritingAndOriginationFees	-64857
	lmfa	Proceeds From Underwriting And Origination Fees ProceedsFromUnderwritingAndOriginationFees	-2055
	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	185785
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	246914
	lmfa	Proceeds From Investment In Note Receivable ProceedsFromInvestmentInNoteReceivable	1500000
	lmfa	Loan To Purchase Securities LoanToPurchaseSecurities	1784250
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	3185
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-551094
	lmfa	Repayment Of Loan To Purchase Securities RepaymentOfLoanToPurchaseSecurities	1784250
	lmfa	Payments To Acquire Investment In Unconsolidated Affiliate PaymentsToAcquireInvestmentInUnconsolidatedAffiliate	5738000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5775665
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1344697
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	96257
	us-gaap	Repayments Of Debt RepaymentsOfDebt	28534
	us-gaap	Repayments Of Annuities And Investment Certificates RepaymentsOfAnnuitiesAndInvestmentCertificates	69540
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9544623
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2946480
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1250000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9419832
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4312725
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	10620747
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	5218683
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1069823
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	22173690
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6288506
	us-gaap	Interest Paid Net InterestPaidNet	1892
	us-gaap	Interest Paid Net InterestPaidNet	12626
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2834925
CY2020Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	128847
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2412678
CY2020Q2	lmfa	Common Stock Value Issued For Cash CommonStockValueIssuedForCash	1250000
CY2020Q2	lmfa	Stock Issued For Warrants Exercised StockIssuedForWarrantsExercised	2946480
CY2020Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	3397
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-437968
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6174587
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	11468308
CY2021Q1	lmfa	Stock Issued For Warrants Exercised StockIssuedForWarrantsExercised	9544623
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	4548299
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25561230
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	11254339
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	36815569
CY2021Q2	lmfa	Number Of Subsidiaries Created NumberOfSubsidiariesCreated	2
	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors
CY2020Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5414296
CY2020	lmfa	Delinquent Assessments DelinquentAssessments	148000
	lmfa	Accrued Interest And Late Fee AccruedInterestAndLateFee	67000
	lmfa	Maximum Future Contingent Payments MaximumFutureContingentPayments	23600
CY2021Q2	us-gaap	Notes Receivable Net NotesReceivableNet	53000
CY2020Q4	us-gaap	Notes Receivable Net NotesReceivableNet	53000
	lmfa	Delinquent Assessments DelinquentAssessments	148000
CY2020	lmfa	Accrued Interest And Late Fee AccruedInterestAndLateFee	57000
	lmfa	Number Of Units With Delinquent Assessment NumberOfUnitsWithDelinquentAssessment	10
CY2020	lmfa	Number Of Units With Delinquent Assessment NumberOfUnitsWithDelinquentAssessment	20
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.253
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-139675
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.253
CY2021Q2	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	499
CY2020Q4	us-gaap	Notes Payable NotesPayable	282042
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	745000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4658000
CY2021Q2	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2324460
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3238298
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-148257
CY2021Q2	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	480942
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	670019
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-30675
CY2021Q2	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2805402
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3908317
	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-178932
CY2021Q2	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	13781
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	21995
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	39257
CY2021Q2	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2805403
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	3913048
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-139675
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13780
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17264
	lmfa	Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate	0.253
	lmfa	Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate	0.253
CY2021Q2	lmfa	Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate	0.253
CY2020Q2	lmfa	Effective Income Tax Rate Reconciliation At Federal And State Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalAndStateStatutoryIncomeTaxRate	0.253
CY2021Q2	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	2818684
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.250
CY2020Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.000
	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3928774
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.000
CY2020Q2	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.000
	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1538
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.000
	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.000
CY2021Q2	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-2805403
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.249
CY2020Q2	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.000
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3913048
	us-gaap	Lease Cost LeaseCost	47483
	us-gaap	Lease Cost LeaseCost	50109
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.252
	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	139675
	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.253
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
CY2020Q2	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	13780
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.001
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17264
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.001
CY2020Q4	lmfa	Deferred Tax Liabilities Assets Deferred Expense Capitalized Software DeferredTaxLiabilitiesAssetsDeferredExpenseCapitalizedSoftware	-1814
CY2020Q4	lmfa	Deferred Tax Liabilities Assets Property Plant And Equipment DeferredTaxLiabilitiesAssetsPropertyPlantAndEquipment	-2916
CY2020Q4	lmfa	Deferred Income Tax Liabilities Assets DeferredIncomeTaxLiabilitiesAssets	-4730
CY2021Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5262
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3913579
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	124876
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	124876
CY2021Q2	lmfa	Deferred Tax Assets Tax Step Up In Basis Purchase Of Noncontrolling Interest DeferredTaxAssetsTaxStepUpInBasisPurchaseOfNoncontrollingInterest	47627
CY2020Q4	lmfa	Deferred Tax Assets Tax Step Up In Basis Purchase Of Noncontrolling Interest DeferredTaxAssetsTaxStepUpInBasisPurchaseOfNoncontrollingInterest	49950
CY2021Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	33466
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Provision For Loan Losses DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses	33466
CY2020Q4	us-gaap	Deferred Tax Liabilities Deferred Expense DeferredTaxLiabilitiesDeferredExpense	20573
CY2021Q2	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	727914
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4653496
CY2021Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	745178
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4658226
CY2021Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	17264
CY2021Q2	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	2800000
CY2021Q2	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	2800000
	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	3900000
	us-gaap	Deferred Taxes Business Combination Valuation Allowance Available To Reduce Income Tax Expense DeferredTaxesBusinessCombinationValuationAllowanceAvailableToReduceIncomeTaxExpense	3900000
	lmfa	Lease Expiration Period LeaseExpirationPeriod	P37M
CY2021Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.065
	lmfa	Lease Contract Beginning Date LeaseContractBeginningDate	2014-03-01
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2019-07-31
CY2021Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	22600
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	47500
CY2020Q2	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	20000
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	50000
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	22627
CY2020Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	20377
	us-gaap	Operating Lease Cost OperatingLeaseCost	47483
	us-gaap	Operating Lease Cost OperatingLeaseCost	50109
CY2021Q2	us-gaap	Lease Cost LeaseCost	22627
CY2020Q2	us-gaap	Lease Cost LeaseCost	20377
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2360
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	422.45
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3400
CY2021Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3860
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	302.55
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	2718012
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.20
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	771857
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	26.80
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	110870
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	160667
CY2021Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	121295
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	171648
CY2021Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0655
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0655
	us-gaap	Operating Lease Payments OperatingLeasePayments	50353
	us-gaap	Operating Lease Payments OperatingLeasePayments	45742
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	108611
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	12684
CY2021Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	121295
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.55
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.55
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.55
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3860
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	302.55
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod	2326112
	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	4.08
	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod	245540
	lmfa	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodWeightedAverageGrantDateFairValue	12.00
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	391900
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.35
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	546317
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	34.15
	lmfa	Debt Instrument Amount Funded For Transaction DebtInstrumentAmountFundedForTransaction	1666500
	lmfa	Part Of Transaction Purchased Amount PartOfTransactionPurchasedAmount	3333500
CY2021Q2	lmfa	Stock Issued Shares For Warrants Exercised StockIssuedSharesForWarrantsExercised	5956544
	lmfa	Stock Issued For Warrants Exercised StockIssuedForWarrantsExercised	8500000
CY2021Q1	lmfa	Gain Loss On Loan Agreement GainLossOnLoanAgreement	5700000
CY2021Q1	lmfa	Amount Of Loans Receivables Acquired AmountOfLoansReceivablesAcquired	18000000
CY2021Q1	lmfa	Cost Associated With Acquisition Of Receivables Loan CostAssociatedWithAcquisitionOfReceivablesLoan	15500000
CY2021Q1	lmfa	Proceeds From Sale Of Own Shares ProceedsFromSaleOfOwnShares	32600000
CY2021Q1	lmfa	Provision For Investor ProvisionForInvestor	11300000

Files In Submission

Name	View Source	Status
0001564590-21-044649-index-headers.html	Edgar Link	pending
0001564590-21-044649-index.html	Edgar Link	pending
0001564590-21-044649.txt	Edgar Link	pending
0001564590-21-044649-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lmfa-10q_20210630.htm	Edgar Link	pending
lmfa-10q_20210630_htm.xml	Edgar Link	completed
lmfa-20210630.xsd	Edgar Link	pending
lmfa-20210630_cal.xml	Edgar Link	unprocessable
lmfa-20210630_def.xml	Edgar Link	unprocessable
lmfa-20210630_lab.xml	Edgar Link	unprocessable
lmfa-20210630_pre.xml	Edgar Link	unprocessable
lmfa-ex311_7.htm	Edgar Link	pending
lmfa-ex312_8.htm	Edgar Link	pending
lmfa-ex321_6.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LMFA
LM FUNDING AMERICA, INC. Stock $lmfa

2021 Q2 Form 10-Q Financial Statement

#000156459021044649 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMFA LM FUNDING AMERICA, INC. Stock $lmfa

2021 Q2 Form 10-Q Financial Statement

#000156459021044649 Filed on August 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LMFA
LM FUNDING AMERICA, INC. Stock $lmfa